Home NDC 10122-502 Revcovi
Product NDC 10122-502
11-digit product format 101220502
Labeler code 10122
Product ID 10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name elapegademase-lvlr
Dosage form INJECTION
Route INTRAMUSCULAR
Labeler Chiesi USA, Inc.
Application BLA761092
Marketing category BLA
Marketing start 2018-10-05
Substance ELAPEGADEMASE
Active strength 1.6 mg/mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Revcovi
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ELAPEGADEMASE 1.6 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9R3D3Y0UHS Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2059223 Internal RxNorm lookup 2059228 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 10122-502-01 Revcovi 1.5 mL in 1 VIAL INJECTION 1.5 5 10122-502-01 Revcovi 1 in 1 CARTON INJECTION 1 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 10122-502 REVCOVI (ELAPEGADEMASE-LVLR) INJECTION [CHIESI USA, INC.] 5 Current NDC, Legacy NDC, 2 package rows 20220902_8c073f84-cdd0-40e4-b3a9-172687267f28.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761092 Revcovi elapegademase-lvlr 351(a) Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 10122-502-01 10122050201 1 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL 1 vial 2018-10-05 0000-00-00 No No Current